Get started
Author

Kynann P. Aninditha

Observed names: K. P. Aninditha, K.P. Aninditha, Kynann Aninditha, Kynann Putra Aninditha
ORCID: 0009-0001-4651-5558
Observed ORCID: 0009-0001-4651-5558
OpenAlex ID: A5074433762
In vitro sensitivity of malignant melanoma cells lines to photon and heavy ion radiation
2019 · K.P. Aninditha, K.J. Weber, et al. · Clinical and Translational Radiation Oncology · 14
PDF
Short-course radiotherapy versus long-course chemoradiotherapy in total neoadjuvant therapy of rectal cancer – A multicenter analysis of early outcomes and toxicity
2025 · Georg Wurschi, Miriam Kesselmeier, et al. · Radiotherapy and Oncology · 7
PDF
Adverse Events After Metastases-Directed Stereotactic Radiotherapy and Biological Cancer Therapy
2026 · Esmée L. Looman, Stephanie G. C. Thoma, et al. · JAMA Network Open · 5
Intraoperative radiation therapy for brain metastasis in a pregnant patient: a case report
2024 · K. P. Aninditha, S. Baumbach, et al. · Strahlentherapie und Onkologie · 4
TNTox – Outcome und Toxizität nach totaler neoadjuvanter Therapie beim Rektumkarzinom: Eine multizentrische Analyse der jDEGRO Trial Group
2024 · Georg Wurschi, Matthias Mäurer, et al. · Forum · 3
Use of surface tracking recordings to identify pitfalls during surface-guided radiotherapy
2024 · G. Klumpp, S. Baumbach, et al. · Strahlentherapie und Onkologie · 2
Clinical and treatment-related predictors of complete response after total neoadjuvant therapy for rectal cancer in a large multicenter analysis
2026 · Georg W. Wurschi, Melanie Schneider, et al. · Clinical and Translational Radiation Oncology · 1
PDF
Spatially Fractionated Induction Radiotherapy to Widen the Therapeutic Window in Locally Advanced Non–Small-Cell Lung Cancer (SPARROW): Study Protocol of a Multicenter, Randomized, Open-Label Seamless Phase I/II Trial
2026 · Sebastian Regnery, Markus Ehle, et al. · Clinical Lung Cancer
PDF
1786 Sex-specific differences in outcomes and toxicity after total neoadjuvant therapy for locally advanced rectal cancer
2026 · Maike Trommer, Melanie Schneider, et al. · Radiotherapy and Oncology
Oxaliplatin‐induced neuropathy after total neoadjuvant therapy for rectal cancer: Dose–response relationship and impact on quality of life
2026 · Georg W. Wurschi, Andreas Hinz, et al. · International Journal of Cancer
PDF
2378 Clinical Application of CBCT-based Online Adaptive Radiotherapy (oART) for Bladder Cancer
2025 · Kynann P. Aninditha, Tarek Ellethy, et al. · Radiotherapy and Oncology
2353 Clinical and Dosimetric Insights from the First 100 Patients Treated with CBCT-based Online Adaptive Radiotherapy: A Single-Institution Evaluation
2025 · Saib Rinnawi, Kynann P. Aninditha, et al. · Radiotherapy and Oncology
2229 Dose-effect relationship on response rates and toxicity in total neoadjuvant therapy for locally advanced rectal cancer – A multicenter analysis
2025 · Georg W. Wurschi, Miriam Kesselmeier, et al. · Radiotherapy and Oncology
2182 Short-course radiotherapy versus chemoradiotherapy in total neoadjuvant therapy of rectal cancer – A multicenter analysis of outcomes and toxicity
2025 · Georg W. Wurschi, Miriam Kesselmeier, et al. · Radiotherapy and Oncology
3083 Toxicity of concurrent biological cancer therapy and stereotactic radiotherapy: a comparison of retrospective and prospective data collection
2025 · Esmée L. Looman, Stephanie G.C. Kroeze, et al. · Radiotherapy and Oncology
4342 International Multicenter Evaluation of Limbic System Coverage in Radiation Treatment Planning for High-Grade Glioma
2025 · Lara Caglayan, Christina Leitzen, et al. · Radiotherapy and Oncology
Works count: 16
Citation count: 36
H-index: 4
I10-index: 1
Year
Topic
Type